FLORHAM PARK, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a clinical‑stage global biopharmaceutical company focused on developing cancer therapeutics, today announced its unaudited financial results for the quarter ended March 31, 2025, and provided a corporate update.
BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update
Seeking Alpha / 1 hour ago 1 Views
Comments